XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.300
+0.040 (3.17%)
May 12, 2025, 4:00 PM - Market closed
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $11.10 million as of May 12, 2025. Its market cap has decreased by -26.00% in one year.
Market Cap
11.10M
Enterprise Value
10.07M
1-Year Change
-26.00%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $11.10M, a decrease of -93.83%. That is a compound annual growth rate of -13.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |